La prise en charge des patients souffrant d’une maladie coronaire en France en 2004-Reference-Cited by-同舟云学术

La prise en charge des patients souffrant d’une maladie coronaire en France en 2004

Published:2006-08 Issue:7-8 Volume:35 Page:1123-1130
ISSN:0755-4982
Container-title:La Presse Médicale
language:fr
Short-container-title:La Presse Médicale

Author:

Jeantet Marine,Gosselin Sophie,Lefrand Emeline,Hunold Hervé,Vanbockstael Vincent,Bertrand Dominique,Danchin Nicolas

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003; 362: 782-8.

2. Randomided trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S);Lancet,1994

3. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels;Sacks;N Engl J Med,1996

4. Évolution de la prescription de prévention secondaire chez les coronariens après revascularisation: enquête ANCOR (analyse nationale de la prise en charge de la maladie coronaire avant et après revascularisation);Jullien;Annales de Cardiologie et d’Angéiologie,2005

5. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial;Shepherd;Lancet,2002

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deleted article: 10.1007/BF03262468;American Journal of Cardiovascular Drugs;2014-11-19

2. Distribution of left ventricular ejection fraction and heart rate values in a cohort of stable coronary patients: The INDYCE registry;Archives of Cardiovascular Diseases;2010-06

3. Pharmacoepidemiological research using French reimbursement databases: yes we can!;Pharmacoepidemiology and Drug Safety;2010-02-03

4. Trends in secondary prevention of ischaemic heart disease in the UK 1994 2005: use of individual and combination treatment;Heart;2008-01-01